Marc Grasso
CFO
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Kyverna Therapeutics, Inc. (KYTX) | Chief Financial Officer | $256,961 | $1,663,536 |
| 2024 | Alector, Inc. (ALEC) | Chief Financial Officer | $514,777 | $1,687,869 |
| 2023 | Alector, Inc. (ALEC) | Chief Financial Officer | $496,800 | $1,715,846 |
| 2022 | Kura Oncology, Inc. (KURA) | Former Chief Financial Officer and Chief Business Officer | $45,608 | $1,694,717 |
| 2022 | Alector, Inc. (ALEC) | Chief Financial Officer | $432,923 | $6,011,780 |
| 2021 | Kura Oncology, Inc. (KURA) | Former Chief Financial Officer and Chief Business Officer | $446,300 | $4,356,608 |
| 2020 | Kura Oncology, Inc. (KURA) | Former Chief Financial Officer and Chief Business Officer | $415,000 | $1,589,108 |
| 2019 | Kura Oncology, Inc. (KURA) | Former Chief Financial Officer and Chief Business Officer | $387,750 | $2,112,282 |
| 2018 | Kura Oncology, Inc. (KURA) | M.D.^(^^4)^ Chief Financial Officer and Chief Business Officer | $136,876 | $3,634,267 |
Executive changes
Earnings-call appearances
-
Kura Oncology, Inc. Q3 FY2021 Earnings Call2021-11-04
Kura Oncology, Inc. (KURA)
-
Kura Oncology, Inc. Q2 FY2021 Earnings Call2021-08-05
Kura Oncology, Inc. (KURA)
-
Kura Oncology, Inc. Q1 FY2021 Earnings Call2021-05-06
Kura Oncology, Inc. (KURA)
-
Kura Oncology, Inc. Q4 FY2020 Earnings Call2021-02-24
Kura Oncology, Inc. (KURA)
-
Kura Oncology, Inc. Q3 FY2020 Earnings Call2020-11-05
Kura Oncology, Inc. (KURA)
-
Kura Oncology, Inc. Q2 FY2020 Earnings Call2020-08-06
Kura Oncology, Inc. (KURA)
-
Kura Oncology, Inc. Q1 FY2020 Earnings Call2020-05-04
Kura Oncology, Inc. (KURA)